H. Lundbeck (OTCMKTS : HLUBF ) Stock

MWN-AI** Summary

MWN-AI** Analysis

**MWN-AI Summary and Analysis is based on asking OpenAI to summarize and analyze this news release.

Description

H. Lundbeck AS is a pharmaceutical firm that focuses on the development and commercialization of central nervous system, or CNS, drugs including antidepressants, antipsychotics, and antiepileptic products. The company's portfolio includes Abilify Maintena and Rexulti for psychosis, Brintellix/Trintellix for depression, Northera for Parkinson's disease symptoms, Sabril and Onfi for seizures, and Vyepti for migraine prevention. Most of the company's sales are derived in North America, followed by Asia and Europe.

Quote

Last:	$4.82
Change Percent:	0.0%
Open:	$4.82
Close:	$4.82
High:	$4.82
Low:	$4.82
Volume:	100
Last Trade Date Time:	03/11/2026 11:22:51 am

Stock Data

Market Cap:	$1,194,485,455
Float:	198,567,942
Insiders Ownership:	N/A
Institutions:
Short Percent:	N/A
Industry:	Pharmaceuticals
Sector:	Healthcare
Website:
Country:	DK
City: